Mind Club

Data as of 11.07.2026 · Primary sources linked · NOT INVESTMENT ADVICE

Disease Pipeline Tools Obesity

Obesity

Programs, trials, and reported weight change for obesity and overweight.

Data as of 11.07.2026

All studies

Lotiglipron

A Drug-Drug Interaction Study to Examine the Impact of Itraconazole and Cyclosporine on PF-07081532 Pharmacokinetics in Overweight or Obese Adults

Pfizer · Phase 1 · Completed · Enrollment 16

NCT05745701

Participants reaching a weight loss threshold

Participants reaching threshold, %

Source: Cited trial source. The denominator is the source figure, when it states one.

No selected arm reports a responder percent.

Show as table
Arm≥5%≥10%≥15%≥20%
Period 1: PF-07081532n/rn/rn/rn/r
Period 2: Cyclosporine + PF-07081532n/rn/rn/rn/r
Period 3: Itraconazole + PF-07081532n/rn/rn/rn/r

Not shown

  • Period 1: PF-07081532: endpoint not reported
  • Period 2: Cyclosporine + PF-07081532: endpoint not reported
  • Period 3: Itraconazole + PF-07081532: endpoint not reported